Thala_screen/lintas – Developing a Mobile Application to Identify Screening Targets in the Extended Family of Thalassemia

Author:

Susanah Susi1,Sari Nur Melani1,Rakhmilla Lulu Eva2,Febrianti Sindy Amalia1,Permana Dea Aprilianti2,Winyarti Winyarti1

Affiliation:

1. Dr. Hasan Sadikin General Hospital, Universitas Padjadjaran

2. Universitas Padjadjaran

Abstract

Abstract Background Thalassemia poses a double burden on medical care and healthcare financing. Due to the high prevalence and the number of affected people which tends to increase in Indonesia, a national prevention and control program is the best rational approach to be implemented. Tailoring to limited resources, screening through the cascade method within extended families with thalassemia patients as index cases seems to be an appropriate approach. To address this, the Thala_screen/LINTAS mobile application was developed as a tool to determine screening targets within extended families with index cases. Methods The development of the application followed four phases. Firstly, content creation involved literature research, discussions with five experts, and pedigree design. Secondly, a trial phase by a forum group discussion was conducted with 30 subjects to evaluate the application's acceptability and user experience through quantitative and qualitative research. Thirdly, content validation was performed using an assessment sheet, which was reviewed by the experts twice. Lastly, a usability study was conducted with 25 parents of thalassemia patients at Hasan Sadikin General Hospital, using ABCs questionnaires after using the application. Results The application's content data was aligned with its objectives, including family demographic data presented in a pedigree chart. The initial dataset included thalassemia registry data. Quantitative research showed an 80.25% acceptability rate, while qualitative research indicated that the application provided was relevant, useful, and presented in an appealing format. However, accessibility received an unsatisfactory response initially, which improved after reevaluation, raising the total validity index from 0.63 to 0.86. The usability study revealed favorable mean scores for the action (2.92) and behavior (0.85) sections, indicating the subjects' interest and ease of using the application. Conclusion This study showed that the Thala_screen mobile application was an acceptable and feasible tool for identifying thalassemia carrier screening targets in extended families.

Publisher

Research Square Platform LLC

Reference38 articles.

1. Kwiatkowski JL. Thalassemia syndromes. In: Kliegman RM, ST Geme JW III, Blum NJ, Shah SS, Tasker RC, Wilson KM, et al. editors. Nelson textbook of pediatrics. 21st ed. Philadelphia: Elsevier; 2020. pp. 2554–8.

2. Cappellini M, Farmakis D, Porter J, Taher A. 2021 Guidelines for the management of transfusion dependent thalassemia (TDT). 4th ed. Cyprus: Thalassemia International Federation; 2021.

3. Eleftheriou A, Angastiniotis M. Global Thalassaemia Review 2022. Cyprus: Thalassaemia International Federation; 2022.

4. The Ministry of Health of Indonesia. Talasemia Penyakit Keturunan, Hindari dengan Deteksi Dini. 2022. https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220510/5739792/talasemia-penyakit-keturunan-hindari-dengan-deteksi-dini/. Accessed 18 June 2023.

5. World Health Organization. Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. New Delhi: World Health Organization, Regional Office for South-East Asia; 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3